120 related articles for article (PubMed ID: 11277526)
1. Synthesis and antitumor activity of novel paclitaxel-chlorambucil hybrids.
Wittman MD; Kadow JF; Vyas DM; Lee FL; Rose WC; Long BH; Fairchild C; Johnston K
Bioorg Med Chem Lett; 2001 Mar; 11(6):811-4. PubMed ID: 11277526
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and antitumor properties of glycosylated antitumor ether lipid (GAEL)- chlorambucil-hybrids.
Idowu T; Samadder P; Arthur G; Schweizer F
Chem Phys Lipids; 2016 Jan; 194():139-48. PubMed ID: 26188768
[TBL] [Abstract][Full Text] [Related]
3. 2-[N1-2-pyrimidyl-aminobenzenesulfonamido] ethyl 4-bis(2-chloroethyl) aminophenyl butyrate: a potent antitumor agent.
Huang Z; Yang G; Lin Z; Huang J
Bioorg Med Chem Lett; 2001 May; 11(9):1099-103. PubMed ID: 11354353
[TBL] [Abstract][Full Text] [Related]
4. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
Lee FY; Borzilleri R; Fairchild CR; Kim SH; Long BH; Reventos-Suarez C; Vite GD; Rose WC; Kramer RA
Clin Cancer Res; 2001 May; 7(5):1429-37. PubMed ID: 11350914
[TBL] [Abstract][Full Text] [Related]
5. Thermoresponsive chlorambucil derivatives for tumour targeting.
Clavel CM; Zava O; Schmitt F; Kenzaoui BH; Nazarov AA; Juillerat-Jeanneret L; Dyson PJ
Angew Chem Int Ed Engl; 2011 Jul; 50(31):7124-7. PubMed ID: 21688360
[No Abstract] [Full Text] [Related]
6. [Result of antineoplastic agents screening: 7th report].
Gan To Kagaku Ryoho; 1998 Mar; 25 Suppl 2():147-392. PubMed ID: 9551093
[No Abstract] [Full Text] [Related]
7. Synthesis of metabolically blocked paclitaxel analogues.
Wittman MD; Altstadt TJ; Fairchild C; Hansel S; Johnston K; Kadow JF; Long BH; Rose WC; Vyas DM; Wu MJ; Zoeckler ME
Bioorg Med Chem Lett; 2001 Mar; 11(6):809-10. PubMed ID: 11277525
[TBL] [Abstract][Full Text] [Related]
8. Hybrid of DNA-targeting Chlorambucil with Pt(IV) Species to Reverse Drug Resistance.
Chen F; Xu G; Qin X; Jin X; Gou S
J Pharmacol Exp Ther; 2017 Nov; 363(2):221-239. PubMed ID: 28916659
[TBL] [Abstract][Full Text] [Related]
9. New synthetic inhibitors of microtubule depolymerization.
Klar U; Graf H; Schenk O; Röhr B; Schulz H
Bioorg Med Chem Lett; 1998 Jun; 8(11):1397-402. PubMed ID: 9871773
[TBL] [Abstract][Full Text] [Related]
10. Glucocorticoids interfere with therapeutic efficacy of paclitaxel against human breast and ovarian xenograft tumors.
Sui M; Chen F; Chen Z; Fan W
Int J Cancer; 2006 Aug; 119(3):712-7. PubMed ID: 16496381
[TBL] [Abstract][Full Text] [Related]
11. Effect of Paclitaxel on Antitumor Activity of Cyclophosphamide: Study on Two Transplanted Tumors in Mice.
Kaledin VI; Nikolin VP; Popova NA; Pyshnaya IA; Bogdanova LA; Morozkova TS
Bull Exp Biol Med; 2015 Nov; 160(1):81-3. PubMed ID: 26597686
[TBL] [Abstract][Full Text] [Related]
12. Drug resistance in the treatment of sarcomas.
Colvin OM
Semin Oncol; 1997 Oct; 24(5):580-91. PubMed ID: 9344325
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vitro efficacy of transferrin conjugates of the anticancer drug chlorambucil.
Beyer U; Roth T; Schumacher P; Maier G; Unold A; Frahm AW; Fiebig HH; Unger C; Kratz F
J Med Chem; 1998 Jul; 41(15):2701-8. PubMed ID: 9667961
[TBL] [Abstract][Full Text] [Related]
14. Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model.
Vassileva V; Grant J; De Souza R; Allen C; Piquette-Miller M
Cancer Chemother Pharmacol; 2007 Nov; 60(6):907-14. PubMed ID: 17375303
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro evaluation of quaternary ammonium derivatives of chlorambucil and melphalan, anticancer drugs designed for the chemotherapy of chondrosarcoma.
Giraud I; Rapp M; Maurizis JC; Madelmont JC
J Med Chem; 2002 May; 45(10):2116-9. PubMed ID: 11985479
[TBL] [Abstract][Full Text] [Related]
16. Induction of broad drug resistance in small cell lung cancer cells and its reversal by paclitaxel.
Su GM; Davey MW; Davey RA
Int J Cancer; 1998 May; 76(5):702-8. PubMed ID: 9610729
[TBL] [Abstract][Full Text] [Related]
17. Preclinical investigation of tolerance and antitumour activity of new fluorodeoxyglucose-coupled chlorambucil alkylating agents.
Miot-Noirault E; Reux B; Debiton E; Madelmont JC; Chezal JM; Coudert P; Weber V
Invest New Drugs; 2011 Jun; 29(3):424-33. PubMed ID: 20033262
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of paclitaxel-BGL conjugates.
Nemoto H; Katagiri A; Kamiya M; Kawamura T; Matsushita T; Matsumura K; Itou T; Hattori H; Tamaki M; Ishizawa K; Miyamoto L; Abe S; Tsuchiya K
Bioorg Med Chem; 2012 Sep; 20(18):5559-67. PubMed ID: 22892212
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of poly(ethylene glycol) with sulfadiazine and chlorambucil end groups and investigation of its antitumor activity.
Jia Z; Zhang H; Huang J
Bioorg Med Chem Lett; 2003 Aug; 13(15):2531-4. PubMed ID: 12852959
[TBL] [Abstract][Full Text] [Related]
20. A novel synthetic DNA minor groove binder, MS-247: antitumor activity and cytotoxic mechanism.
Matsuba Y; Edatsugi H; Mita I; Matsunaga A; Nakanishi O
Cancer Chemother Pharmacol; 2000; 46(1):1-9. PubMed ID: 10912571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
